查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
子宮內膜異位症全球市場規模/份額/行業趨勢分析報告，按類型、治療方法（口服避孕藥、GnRH製劑、其他）、分銷渠道、地區展望/預測2022-2028
市場調查報告書
商品編碼
1219646

子宮內膜異位症全球市場規模/份額/行業趨勢分析報告，按類型、治療方法（口服避孕藥、GnRH製劑、其他）、分銷渠道、地區展望/預測2022-2028

Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 204 Pages | 訂單完成後即時交付

價格

子宮內膜異位症的全球市場規模預計將在 2028 年達到 22 億美元，預測期內復合年增長率為 11.6%。

子宮內膜異位症斑塊往往很“粘”，可以將器官連接在一起。 粘連是這些情況的醫學術語。 例如，腸子和膀胱可能會“粘”在子宮上。 大的子宮內膜異位斑塊可發展成囊腫，在每月月經期間出血。 這種囊腫被稱為“巧克力囊腫”，可能會因黑血而腫脹。

在沒有正式診斷的情況下，許多子宮內膜異位症患者僅根據症狀進行治療。 在某些情況下，可以通過稱為腹腔鏡檢查的簡單程序做出明確診斷。 對於此過程，在腹部做一個小切口（通常為 1.5 厘米或更小），然後通過它插入一個照相機以觀察骨盆內部。 可以進行活組織檢查（一小部分組織樣本）。

COVID-19 影響分析

COVID-19 大流行對子宮內膜異位症市場產生了負面影響，因為它大規模重組了世界各地的醫學院和醫院，以擴大 COVID-19 患者的醫院容量。預計會給 在大流行期間，子宮內膜異位症治療的發展和發現放緩，但並未停止。 醫療保健提供者只接受緊急病例，並為不太嚴重的病例提供更多的家庭護理。 此外，生產設施關閉和明膠等原材料短缺嚴重擾亂了子宮內膜異位症藥物的供應鏈。

市場增長因素

政府努力提高對子宮內膜異位症的認識

在與初級保健機構有良好聯繫的三級和二級保健機構中建立高級診斷成像、藥物、手術、生育治療和多學科干預的轉診網絡和護理途徑。 通過增加工具（如超聲和磁共振成像）和藥物的可用性，衛生系統可以更好地早期發現和治療子宮內膜異位症（複方口服避孕藥、非甾體鎮痛藥）、藥物、黃體酮類避孕藥等。 ). 一些主要政府機構的宣傳計劃和其他宣傳活動將推動市場增長。 預計這將在預測期內進一步推動市場增長。

子宮內膜異位症等婦科疾病發病率增加

子宮內膜異位症是一種類似於子宮內膜的組織生長在子宮外，導致疼痛和不孕的疾病。 據估計，全世界約有 10% 的育齡婦女和青少年（1.9 億人）患有子宮內膜異位症。 子宮內膜異位症會引起月經、性交、排便、膀胱運動、慢性盆腔不適、胃脹、噁心、疲勞等難以忍受的危及生命的症狀，有時還會出現抑鬱、焦慮和不孕等症狀。它是一種引起疼痛的慢性疾病影響

市場製約因素

目前還沒有針對子宮內膜異位症的非侵入性診斷測試。

診斷測試的實用性和有效性主要取決於其對特定疾病的敏感性和特異性。 然而，了解這些措施並將其應用於臨床決策有時可能具有挑戰性。 陽性或陰性測試足以確定患者是否患有疾病的可能性稱為陽性預測值 (PPV) 或陰性預測值 (NPV)。 由於缺乏合適和有效的診斷設備，子宮內膜異位症市場預計增長緩慢。

按類型劃分的前景

按類型，子宮內膜異位症市場分為淺表腹膜病變、子宮內膜異位症等。 到 2021 年，淺表腹膜病變部分將在子宮內膜異位症市場中佔據最高的收入份額。 這是淺表腹膜病變發病率上升以及提高對子宮內膜異位症認識的計劃創建的結果。 此外，增加政府對子宮內膜異位症研究的資助正在加速淺表腹膜病變部分的發展。

分銷渠道前景

子宮內膜異位症市場按分銷渠道分為醫院藥店、網上藥店和零售藥店。 2021 年，醫院藥房部門在子宮內膜異位症市場的收入份額最大。 這是由於醫院藥房的擴張以及患者對醫院作為優質護理提供者的信任度增加。 醫院藥房市場主要受到子宮內膜異位症治療替代手術的上升趨勢的推動。 醫院藥師還具有豐富的藥物知識，可以幫助子宮內膜異位症患者及其護理人員選擇合適的藥物。 所有這些因素都在推動該行業的擴張。

治療景觀

子宮內膜異位症市場按治療方法細分為口服避孕藥、促性腺激素釋放激素 (GnRH) 製劑等。 2021 年，促性腺激素釋放激素 (GnRH) 藥物細分市場將在子宮內膜異位症市場中佔據顯著的收入份額。 它們有片劑、注射劑、注射劑和滴鼻劑。 Orilissa (Elagolix) 由 AbbVie Inc. 製造，是 FDA 批准的第一種緩解疾病相關疼痛的藥物。 GnRH 激動劑和拮抗劑應被視為對一線藥物耐藥的患者的替代藥物。

區域展望

按地區分析了北美、歐洲、亞太地區和 LAMEA 的子宮內膜異位症市場。 北美地區在 2021 年的收入份額最大的子宮內膜異位症市場佔據主導地位。 這主要是由於需要促性腺激素釋放激素（GnRH）藥物等額外治療的子宮內膜異位症患者數量增加、政府對子宮內膜異位症研究的資助增加以及發達國家資本收入大幅增加等。 此外，旨在降低支出水平的複雜報銷系統也有助於擴大市場。

內容

第1章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球子宮內膜異位症市場，按類型
    • 全球子宮內膜異位症市場，按治療分類
    • 全球子宮內膜異位症市場，按分銷渠道
    • 全球子宮內膜異位症市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章全球子宮內膜異位症市場：按類型

  • 世界淺表腹膜病變市場：按地區
  • 全球子宮內膜異位症市場：按地區
  • 世界其他地區市場

第 4 章全球子宮內膜異位症市場：按治療分類

  • 全球口服避孕藥市場：按地區
  • 按地區劃分的促性腺激素釋放激素 (GnRH) 產品的全球市場
  • 其他世界市場：按地區

第 5 章全球子宮內膜異位症市場：按分銷渠道

  • 全球住院藥房市場：按地區
  • 全球零售藥店市場，按地區
  • 全球在線藥店市場：按地區

第 6 章全球子宮內膜異位症市場：按地區

  • 北美
    • 北美國家/地區的子宮內膜異位症市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲子宮內膜異位症市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區按國家/地區劃分的子宮內膜異位症市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 子宮內膜異位症市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他拉美地區

第7章公司簡介

  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Consilient Health Limited

The Global Endometriosis Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.6% CAGR during the forecast period.

Endometrial-like tissue that arises in unintended places is a typical symptom of endometriosis. The tissue that develops and sheds in the uterus is known as endometrial tissue. The majority of the time, this growth occurs on and around pelvic cavity organs. Similar to the tissue inside the uterus, endometrial tissue undergoes growth, thickening, and attempts at shedding with each menstrual cycle.

The tissue can result in adhesions, tumors, and lesions that set off an inflammatory reaction since it has no way to leave the body. This may result in discomfort and other issues, such as infertility. Over the years, various causes of endometriosis have been proposed. The endometrium is the name for the lining of the uterus. According to one notion, endometrial cells can go from the uterus to the pelvic region. When a patient has a period, they pour backward along the Fallopian tubes and end up there.

Endometriosis patches have a tendency to be "sticky" and can connect organs. Adhesions are the medical word for this. The gut or bladder, for instance, could "stuck" to the uterus. Large endometriosis patches might develop into cysts that bleed every month during menstruation. The cysts are referred to as "chocolate cysts" and might swell up with black blood.

Without a formal diagnosis, many endometriosis patients receive treatment based solely on their symptoms. In some instances, a laparoscopy, a straightforward surgery, is used to provide an authoritative diagnosis. In this operation, a tiny abdominal incision (often less than 1.5cm/0.6 inches) is made, through which a camera is inserted to view the pelvic cavity. Biopsies, or small tissue samples, can be taken.

COVID-19 Impact Analysis

The COVID-19 outbreak is projected to have a negative effect on the endometriosis market due to the massive restructuring of medical schools and hospitals around the world to expand hospital capacity for COVID-19 patients. During the pandemic, the development and discovery of endometriosis treatments slowed but did not stop. Healthcare providers were only accepting emergency cases and suggested home care more to the less important cases. Moreover, the shutdown of production facilities and the lack of raw materials like gelatin significantly interrupted the supply chain for endometriosis medications.

Market Growth Factors

Government efforts to raise endometriosis awareness

Establishing referral networks and care pathways with advanced imaging, pharmaceutical, surgical, fertility, and multidisciplinary interventions at tertiary and secondary centers with good connections to primary healthcare facilities. Increasing the availability of tools (such as ultrasound or magnetic resonance imaging) and medications will help health systems be better equipped to detect and treat endometriosis early (e.g., combined oral contraceptives, non-steroidal analgesics, and progestin-based contraceptives). The market growth will be boosted by numerous significant governmental entities conducting programs and other awareness programs to raise awareness. This would increasingly support the market growth during the projection period.

Increasing incidence of gynecological disorders such as endometriosis

Endometriosis is a condition in which tissue that resembles the uterine lining grows outside of the uterus, resulting in pain and/or infertility. Around 10% (190 million) of women and adolescents of reproductive age suffer from endometriosis worldwide. It is a chronic condition that causes excruciating, life-altering agony during periods, sexual activity, bowel and/or bladder movements, chronic pelvic discomfort, stomach bloating, nausea, exhaustion, and occasionally depression, anxiety, and infertility.

Market Restraining Factors

The absence of non-invasive endometriosis diagnostic tests

A diagnostic test's usefulness and validity are primarily determined by its sensitivity and specificity for a certain ailment. However, it can occasionally be challenging to comprehend and apply these measures to clinical decision-making. The likelihood that a positive or negative test would properly identify whether a patient has the condition is known as the positive predictive value (PPV) or negative predictive value (NPV). The endometriosis market is predicted to experience slow expansion due to the absence of appropriate and efficient diagnosis devices.

Type Outlook

Based on type, the endometriosis market is segmented into superficial peritoneal lesion, endometriomas and others. The superficial peritoneal lesion segment generated the highest revenue share in the endometriosis market in 2021. This is a result of the increase in the incidence of superficial peritoneal lesions and the creation of programs to raise endometriosis awareness. Additionally, a rise in government financing for endometriosis research has accelerated the development of the superficial peritoneal lesion segment.

Distribution Channel Outlook

On the basis of distribution channel, the endometriosis market is categorized into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the endometriosis market in 2021. This is due to an expansion in hospital pharmacies and a rise in patients' confidence in hospitals as providers of high-quality care. The hospital pharmacy market is primarily driven by the growing trend of endometriosis therapy as an alternative to surgery. Hospital pharmacists can also help endometriosis patients, and their carers choose the right medications because they are knowledgeable about medications. Such elements all encourage sector expansion.

Treatment Outlook

By treatment, the endometriosis market is bifurcated into oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines and others. The gonadotropin-releasing hormone (GnRH) medicines segment recorded a prominent revenue share in the endometriosis market in 2021. They are available as a tablet, injection, shot, or nasal spray. Orilissa (elagolix), manufactured by AbbVie Inc., was the first drug given FDA approval to alleviate disease-related pain. Patients who are resistant to the first line of treatment should consider GnRH agonists and antagonists as alternatives.

Regional Outlook

Region wise, the endometriosis market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region dominated the endometriosis market with maximum revenue share in 2021. This is mostly linked to an increase in endometriosis cases, which necessitate additional treatments such as gonadotropin-releasing hormone (GnRH) medications, an increase in government financing for endometriosis research, and a considerable increase in capital income in developed countries. The sophisticated reimbursement structures that exist and are designed to lower expenditure levels also contribute to the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Superficial Peritoneal Lesion
  • Endometriomas
  • Others

By Treatment

  • Oral Contraceptives
  • Gonadotropin-releasing hormone (GnRH) medicines
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Abbott Laboratories
  • Consilient Health Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Endometriosis Market, by Type
    • 1.4.2 Global Endometriosis Market, by Treatment
    • 1.4.3 Global Endometriosis Market, by Distribution Channel
    • 1.4.4 Global Endometriosis Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Endometriosis Market by Type

  • 3.1 Global Superficial Peritoneal Lesion Market by Region
  • 3.2 Global Endometriomas Market by Region
  • 3.3 Global Others Market by Region

Chapter 4. Global Endometriosis Market by Treatment

  • 4.1 Global Oral Contraceptives Market by Region
  • 4.2 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Endometriosis Market by Distribution Channel

  • 5.1 Global Hospital Pharmacy Market by Region
  • 5.2 Global Retail Pharmacy Market by Region
  • 5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Endometriosis Market by Region

  • 6.1 North America Endometriosis Market
    • 6.1.1 North America Endometriosis Market by Type
      • 6.1.1.1 North America Superficial Peritoneal Lesion Market by Country
      • 6.1.1.2 North America Endometriomas Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Endometriosis Market by Treatment
      • 6.1.2.1 North America Oral Contraceptives Market by Country
      • 6.1.2.2 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.1.2.3 North America Others Market by Country
    • 6.1.3 North America Endometriosis Market by Distribution Channel
      • 6.1.3.1 North America Hospital Pharmacy Market by Country
      • 6.1.3.2 North America Retail Pharmacy Market by Country
      • 6.1.3.3 North America Online Pharmacy Market by Country
    • 6.1.4 North America Endometriosis Market by Country
      • 6.1.4.1 US Endometriosis Market
        • 6.1.4.1.1 US Endometriosis Market by Type
        • 6.1.4.1.2 US Endometriosis Market by Treatment
        • 6.1.4.1.3 US Endometriosis Market by Distribution Channel
      • 6.1.4.2 Canada Endometriosis Market
        • 6.1.4.2.1 Canada Endometriosis Market by Type
        • 6.1.4.2.2 Canada Endometriosis Market by Treatment
        • 6.1.4.2.3 Canada Endometriosis Market by Distribution Channel
      • 6.1.4.3 Mexico Endometriosis Market
        • 6.1.4.3.1 Mexico Endometriosis Market by Type
        • 6.1.4.3.2 Mexico Endometriosis Market by Treatment
        • 6.1.4.3.3 Mexico Endometriosis Market by Distribution Channel
      • 6.1.4.4 Rest of North America Endometriosis Market
        • 6.1.4.4.1 Rest of North America Endometriosis Market by Type
        • 6.1.4.4.2 Rest of North America Endometriosis Market by Treatment
        • 6.1.4.4.3 Rest of North America Endometriosis Market by Distribution Channel
  • 6.2 Europe Endometriosis Market
    • 6.2.1 Europe Endometriosis Market by Type
      • 6.2.1.1 Europe Superficial Peritoneal Lesion Market by Country
      • 6.2.1.2 Europe Endometriomas Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Endometriosis Market by Treatment
      • 6.2.2.1 Europe Oral Contraceptives Market by Country
      • 6.2.2.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.2.2.3 Europe Others Market by Country
    • 6.2.3 Europe Endometriosis Market by Distribution Channel
      • 6.2.3.1 Europe Hospital Pharmacy Market by Country
      • 6.2.3.2 Europe Retail Pharmacy Market by Country
      • 6.2.3.3 Europe Online Pharmacy Market by Country
    • 6.2.4 Europe Endometriosis Market by Country
      • 6.2.4.1 Germany Endometriosis Market
        • 6.2.4.1.1 Germany Endometriosis Market by Type
        • 6.2.4.1.2 Germany Endometriosis Market by Treatment
        • 6.2.4.1.3 Germany Endometriosis Market by Distribution Channel
      • 6.2.4.2 UK Endometriosis Market
        • 6.2.4.2.1 UK Endometriosis Market by Type
        • 6.2.4.2.2 UK Endometriosis Market by Treatment
        • 6.2.4.2.3 UK Endometriosis Market by Distribution Channel
      • 6.2.4.3 France Endometriosis Market
        • 6.2.4.3.1 France Endometriosis Market by Type
        • 6.2.4.3.2 France Endometriosis Market by Treatment
        • 6.2.4.3.3 France Endometriosis Market by Distribution Channel
      • 6.2.4.4 Russia Endometriosis Market
        • 6.2.4.4.1 Russia Endometriosis Market by Type
        • 6.2.4.4.2 Russia Endometriosis Market by Treatment
        • 6.2.4.4.3 Russia Endometriosis Market by Distribution Channel
      • 6.2.4.5 Spain Endometriosis Market
        • 6.2.4.5.1 Spain Endometriosis Market by Type
        • 6.2.4.5.2 Spain Endometriosis Market by Treatment
        • 6.2.4.5.3 Spain Endometriosis Market by Distribution Channel
      • 6.2.4.6 Italy Endometriosis Market
        • 6.2.4.6.1 Italy Endometriosis Market by Type
        • 6.2.4.6.2 Italy Endometriosis Market by Treatment
        • 6.2.4.6.3 Italy Endometriosis Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Endometriosis Market
        • 6.2.4.7.1 Rest of Europe Endometriosis Market by Type
        • 6.2.4.7.2 Rest of Europe Endometriosis Market by Treatment
        • 6.2.4.7.3 Rest of Europe Endometriosis Market by Distribution Channel
  • 6.3 Asia Pacific Endometriosis Market
    • 6.3.1 Asia Pacific Endometriosis Market by Type
      • 6.3.1.1 Asia Pacific Superficial Peritoneal Lesion Market by Country
      • 6.3.1.2 Asia Pacific Endometriomas Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Endometriosis Market by Treatment
      • 6.3.2.1 Asia Pacific Oral Contraceptives Market by Country
      • 6.3.2.2 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.3.2.3 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Endometriosis Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
      • 6.3.3.3 Asia Pacific Online Pharmacy Market by Country
    • 6.3.4 Asia Pacific Endometriosis Market by Country
      • 6.3.4.1 China Endometriosis Market
        • 6.3.4.1.1 China Endometriosis Market by Type
        • 6.3.4.1.2 China Endometriosis Market by Treatment
        • 6.3.4.1.3 China Endometriosis Market by Distribution Channel
      • 6.3.4.2 Japan Endometriosis Market
        • 6.3.4.2.1 Japan Endometriosis Market by Type
        • 6.3.4.2.2 Japan Endometriosis Market by Treatment
        • 6.3.4.2.3 Japan Endometriosis Market by Distribution Channel
      • 6.3.4.3 India Endometriosis Market
        • 6.3.4.3.1 India Endometriosis Market by Type
        • 6.3.4.3.2 India Endometriosis Market by Treatment
        • 6.3.4.3.3 India Endometriosis Market by Distribution Channel
      • 6.3.4.4 South Korea Endometriosis Market
        • 6.3.4.4.1 South Korea Endometriosis Market by Type
        • 6.3.4.4.2 South Korea Endometriosis Market by Treatment
        • 6.3.4.4.3 South Korea Endometriosis Market by Distribution Channel
      • 6.3.4.5 Singapore Endometriosis Market
        • 6.3.4.5.1 Singapore Endometriosis Market by Type
        • 6.3.4.5.2 Singapore Endometriosis Market by Treatment
        • 6.3.4.5.3 Singapore Endometriosis Market by Distribution Channel
      • 6.3.4.6 Malaysia Endometriosis Market
        • 6.3.4.6.1 Malaysia Endometriosis Market by Type
        • 6.3.4.6.2 Malaysia Endometriosis Market by Treatment
        • 6.3.4.6.3 Malaysia Endometriosis Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Endometriosis Market
        • 6.3.4.7.1 Rest of Asia Pacific Endometriosis Market by Type
        • 6.3.4.7.2 Rest of Asia Pacific Endometriosis Market by Treatment
        • 6.3.4.7.3 Rest of Asia Pacific Endometriosis Market by Distribution Channel
  • 6.4 LAMEA Endometriosis Market
    • 6.4.1 LAMEA Endometriosis Market by Type
      • 6.4.1.1 LAMEA Superficial Peritoneal Lesion Market by Country
      • 6.4.1.2 LAMEA Endometriomas Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Endometriosis Market by Treatment
      • 6.4.2.1 LAMEA Oral Contraceptives Market by Country
      • 6.4.2.2 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.4.2.3 LAMEA Others Market by Country
    • 6.4.3 LAMEA Endometriosis Market by Distribution Channel
      • 6.4.3.1 LAMEA Hospital Pharmacy Market by Country
      • 6.4.3.2 LAMEA Retail Pharmacy Market by Country
      • 6.4.3.3 LAMEA Online Pharmacy Market by Country
    • 6.4.4 LAMEA Endometriosis Market by Country
      • 6.4.4.1 Brazil Endometriosis Market
        • 6.4.4.1.1 Brazil Endometriosis Market by Type
        • 6.4.4.1.2 Brazil Endometriosis Market by Treatment
        • 6.4.4.1.3 Brazil Endometriosis Market by Distribution Channel
      • 6.4.4.2 Argentina Endometriosis Market
        • 6.4.4.2.1 Argentina Endometriosis Market by Type
        • 6.4.4.2.2 Argentina Endometriosis Market by Treatment
        • 6.4.4.2.3 Argentina Endometriosis Market by Distribution Channel
      • 6.4.4.3 UAE Endometriosis Market
        • 6.4.4.3.1 UAE Endometriosis Market by Type
        • 6.4.4.3.2 UAE Endometriosis Market by Treatment
        • 6.4.4.3.3 UAE Endometriosis Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Endometriosis Market
        • 6.4.4.4.1 Saudi Arabia Endometriosis Market by Type
        • 6.4.4.4.2 Saudi Arabia Endometriosis Market by Treatment
        • 6.4.4.4.3 Saudi Arabia Endometriosis Market by Distribution Channel
      • 6.4.4.5 South Africa Endometriosis Market
        • 6.4.4.5.1 South Africa Endometriosis Market by Type
        • 6.4.4.5.2 South Africa Endometriosis Market by Treatment
        • 6.4.4.5.3 South Africa Endometriosis Market by Distribution Channel
      • 6.4.4.6 Nigeria Endometriosis Market
        • 6.4.4.6.1 Nigeria Endometriosis Market by Type
        • 6.4.4.6.2 Nigeria Endometriosis Market by Treatment
        • 6.4.4.6.3 Nigeria Endometriosis Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Endometriosis Market
        • 6.4.4.7.1 Rest of LAMEA Endometriosis Market by Type
        • 6.4.4.7.2 Rest of LAMEA Endometriosis Market by Treatment
        • 6.4.4.7.3 Rest of LAMEA Endometriosis Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
  • 7.3 Sun Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Sanofi S.A.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 AbbVie, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Trials and Approvals:
  • 7.6 AstraZeneca PLC
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Partnerships, Collaborations, and Agreements:
      • 7.7.5.2 Trials and Approvals:
  • 7.8 Merck & Co., Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expenses
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Trials and Approvals:
  • 7.9 GlaxoSmithKline PLC
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Trials and Approvals:
      • 7.9.5.2 Acquisition and Mergers:
  • 7.10. Consilient Health Limited
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 2 Global Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 3 Global Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Superficial Peritoneal Lesion Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Superficial Peritoneal Lesion Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Endometriomas Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Endometriomas Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 12 Global Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Contraceptives Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Contraceptives Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 20 Global Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 21 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Endometriosis Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Endometriosis Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 30 North America Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 31 North America Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 32 North America Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 33 North America Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 40 North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 48 North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 49 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 58 US Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 59 US Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 60 US Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 61 US Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 62 US Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 63 US Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 US Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Canada Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 68 Canada Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 69 Canada Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 70 Canada Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 71 Canada Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 72 Canada Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 73 Mexico Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 76 Mexico Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 77 Mexico Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 78 Mexico Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 79 Mexico Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 80 Mexico Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 89 Europe Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 92 Europe Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 93 Europe Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 100 Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 101 Europe Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 108 Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 109 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 120 Germany Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 121 Germany Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 122 Germany Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 123 Germany Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Germany Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 UK Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 126 UK Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 127 UK Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 128 UK Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 129 UK Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 130 UK Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 131 UK Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 132 UK Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 133 France Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 134 France Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 135 France Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 136 France Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 137 France Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 138 France Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 139 France Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 140 France Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 141 Russia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 144 Russia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 145 Russia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 146 Russia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 147 Russia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Russia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Spain Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 152 Spain Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 153 Spain Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 154 Spain Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 155 Spain Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 156 Spain Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 157 Italy Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 160 Italy Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 161 Italy Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 162 Italy Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 163 Italy Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 164 Italy Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 202 China Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 203 China Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 204 China Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 205 China Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 206 China Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 207 China Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 China Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 Japan Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 212 Japan Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 213 Japan Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 214 Japan Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 215 Japan Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 216 Japan Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 217 India Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 218 India Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 219 India Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 220 India Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 221 India Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 222 India Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 223 India Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 224 India Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 225 South Korea Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 228 South Korea Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 229 South Korea Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 230 South Korea Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 231 South Korea Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 South Korea Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Singapore Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 236 Singapore Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 237 Singapore Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 238 Singapore Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 239 Singapore Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 240 Singapore Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 288 Brazil Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 289 Brazil Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 290 Brazil Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 291 Brazil Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 292 Brazil Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 293 Argentina Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 296 Argentina Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 297 Argentina Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 298 Argentina Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 299 Argentina Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 300 Argentina Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 301 UAE Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 304 UAE Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 305 UAE Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 306 UAE Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 307 UAE Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 UAE Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 317 South Africa Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 320 South Africa Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 321 South Africa Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 322 South Africa Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 323 South Africa Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 South Africa Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 341 Key Information - Abbott Laboratories
  • TABLE 342 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 343 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 344 Key Information - Sanofi S.A.
  • TABLE 345 Key information - AbbVie, Inc.
  • TABLE 346 KEY INFORMATION - AstraZeneca PLC
  • TABLE 347 Key Information - Pfizer, Inc.
  • TABLE 348 KEY INFORMATION - Merck & Co., Inc.
  • TABLE 349 Key Information - GlaxoSmithKline PLC
  • TABLE 350 Key Information - Consilient Health Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Endometriosis Market share by Type, 2021
  • FIG 3 Global Endometriosis Market share by Type, 2028
  • FIG 4 Global Endometriosis Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Endometriosis Market share by Treatment, 2021
  • FIG 6 Global Endometriosis Market share by Treatment, 2028
  • FIG 7 Global Endometriosis Market by Treatment, 2018 - 2028, USD Million
  • FIG 8 Global Endometriosis Market share by Distribution Channel, 2021
  • FIG 9 Global Endometriosis Market share by Distribution Channel, 2028
  • FIG 10 Global Endometriosis Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 11 Global Endometriosis Market share by Region, 2021
  • FIG 12 Global Endometriosis Market share by Region, 2028
  • FIG 13 Global Endometriosis Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories